Chest Medicine
Editorial: Lack of Efficacy of Hydroxychloroquine in Covid-19
20 May, 2020 | 10:01h | UTCLack of efficacy of hydroxychloroquine in covid-19 – The BMJ
Original Research: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial – The BMJ
Related Meta-analysis (preprint) Hydroxychloroquine in COVID-19: A systematic review and meta-analysis – medRxiv
Video: Personal Protective Equipment and Covid-19
20 May, 2020 | 09:55h | UTCPersonal Protective Equipment and Covid-19 – New England Journal of Medicine
Cohort Study: Outcomes of Critically Ill Adults with COVID-19 in New York City
20 May, 2020 | 09:56h | UTCCommentaries: Critically ill patients with COVID-19 in New York City – The Lancet AND Nearly 40% of critically ill COVID-19 patients in New York City died, study finds – UPI
Meta-Analysis: Accuracy of Chest CT for detecting COVID-19
20 May, 2020 | 09:49h | UTC
Should Azithromycin be Used to Treat COVID-19?
20 May, 2020 | 09:47h | UTCShould azithromycin be used to treat COVID-19? A rapid review – BJGP Open
Cross-neutralization of SARS-CoV-2 by a Human Monoclonal SARS-CoV Antibody
19 May, 2020 | 04:35h | UTCCross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody – Nature
Commentary: Cross-neutralization of SARS and COVID-19 coronaviruses by a monoclonal antibody – News Medical
Early Data Show Moderna Covid-19 Vaccine Generates Immune Response
19 May, 2020 | 04:29h | UTCEarly data show Moderna Covid-19 vaccine generates immune response – STAT
See also: Moderna Coronavirus Vaccine Trial Shows Promising Early Results – The New York Times AND Expert reaction to Moderna announcement about their phase 1 trial data on their mRNA vaccine (mRNA-1273) candidate against COVID-19 – Science Media Centre
Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology
19 May, 2020 | 04:20h | UTC
New NICE Covid-19 Rapid Guidelines: Chronic Kidney Disease & Interstitial Lung Disease
18 May, 2020 | 02:15h | UTCCOVID-19 rapid guideline: chronic kidney disease – National Institute for Health and Care Excellence
See also: Complete Collection of Covid-19 Rapid Guidelines
Randomized Trial: No Benefit from Hydroxychloroquine in Patients with Mild to Moderate Covid-19
18 May, 2020 | 02:11h | UTCCommentary: Further evidence does not support hydroxychloroquine for patients with COVID-19 – BMJ
Clinical Practice: Severe Covid-19
18 May, 2020 | 02:09h | UTCSevere Covid-19 – New England Journal of Medicine
Hemostasis Disorders in Critically Ill Patients with COVID-19
18 May, 2020 | 02:08h | UTC
Related Commentary on Twitter
Understanding pathophysiology of hemostasis
What is the link between SARS-CoV-2-associated hypoxia, inflammatory response and both hypercoagulability and endotheliopathy observed in #COVID19 patients?! @yourICM https://t.co/xu0M0FiYcr pic.twitter.com/nm2JB9OKTH— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) May 16, 2020
LDH, Lymphocyte Count, and C-reactive protein can Predict Mortality in Covid-19
18 May, 2020 | 01:58h | UTCAn interpretable mortality prediction model for COVID-19 patients – Nature Machine Learning
Related Commentary on Twitter
The importance of 3 blood test results for predicting mortality from #COVID19: LDH, lymphocyte count, and C-reactive protein https://t.co/BpbgLkm6Hs just published @NatMachIntell, a nice example of machine learning deconvoluting risk markers pic.twitter.com/JtBofSdwsM
— Eric Topol (@EricTopol) May 14, 2020
Guidance for Tracheostomy in the COVID-19 Era
18 May, 2020 | 02:05h | UTCCommentary: Walking the line between benefit and harm from tracheostomy in COVID-19 – The Lancet Respiratory Medicine
Clinical and Chest Radiography Features Determine Patient Outcomes In COVID-19
18 May, 2020 | 01:59h | UTC
Risk Factors for SARS-CoV-2 in Patients with Symptoms
18 May, 2020 | 01:55h | UTC
Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure
18 May, 2020 | 01:52h | UTCEditorial: Is the Prone Position Helpful During Spontaneous Breathing in Patients With COVID-19?
Risk factors for SARS-CoV-2 in a Primary Care Network
18 May, 2020 | 01:56h | UTCCommentaries: Who is most likely to be infected with SARS-CoV-2? – The Lancet Infectious Diseases AND Sociodemographic factors associated with a positive test for COVID-19 in primary care – The Lancet AND COVID-19 discriminates along racial, socioeconomic lines, study finds – UPI
Systematic Review: Risks and Impact of ACE Inhibitors or ARBs on SARS-CoV-2 Infection in Adults
18 May, 2020 | 01:47h | UTC
Study: Use of Renin–angiotensin–aldosterone System Inhibitors Does Not Increase the Risk of COVID-19 Requiring Admission to Hospital
18 May, 2020 | 01:45h | UTCCommentary: Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19 – The Lancet
[Preprint] Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients
15 May, 2020 | 03:50h | UTCEarly Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients – medRxiv
Commentary: Convalescent plasma is safe to treat COVID-19: nationwide study – NBC News
Systematic Review: Plasma from People who Have Recovered from COVID-19 to Treat Individuals with COVID-19
15 May, 2020 | 03:48h | UTC
Study: Airborne Lifetime of Small Speech Droplets and their Potential Importance in SARS-CoV-2 Transmission
15 May, 2020 | 03:43h | UTCCommentaries: Expert reaction to study looking at speech-generated droplets and COVID-19 transmission – Science Media Centre AND Loud Talking Can Spread More than 1,000 Coronavirus Particles in the Air for 14 Minutes: Study – The Science Times AND Simply talking in confined spaces may be enough to spread the coronavirus, researchers say – USA Today AND Loud talking could leave coronavirus in the air for up to 14 minutes – MIT Technology Review
ACP Systematic Review: Chloroquine or Hydroxychloroquine Alone or in Combination with Azithromycin for the Prophylaxis or Treatment of COVID-19
15 May, 2020 | 03:32h | UTC
Study Commentary: Before/after Study of Short-Course Steroid in COVID-19
14 May, 2020 | 10:09h | UTCBefore/after study of short-course steroid in COVID-19 – PulmCrit
Original Study (Preprint): Early Short Course Corticosteroids in Hospitalized Patients with COVID-19 – medRxiv